Current peritoneal dialysis compared with haemodialysis: Medium-term survival analysis of incident dialysis patients in the canary Islands in recent years;Diálisis peritoneal actual comparada con hemodiálisis: Análisis de supervivencia a medio plazo en pacientes incidentes en diálisis en la comunidad canaria en los últimos años

Nefrologia

Volumn 31, Issue 2, 2011, Pages 174-184

  Rufino Hernández, Juana Margarita ^a   Garcia C ^b   Vega, N ^c   Macia M ^d   Hernandez D ^e   Rodriguez A ^f   Maceira, B ^a   Lorenzo, V ^a  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^b HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

^c HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^d HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^e HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^f Coordinación Autonómica de Trasplante de Órganos y Tejidos ^*  (Spain)

Author keywords

Biocompatible peritoneal solutions; Haemodialysis; Peritoneal dialysis; Survival on dialysis

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; COMPARATIVE STUDY; DIABETIC NEPHROPATHY; EVALUATION; FEMALE; HUMAN; INFECTION; KAPLAN MEIER METHOD; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MORTALITY; NEOPLASM; PERITONEAL DIALYSIS; PROPORTIONAL HAZARDS MODEL; REGISTER; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; RISK FACTOR; SPAIN; STATISTICS; TREATMENT OUTCOME;

ADULT; AGE FACTORS; AGED; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COHORT STUDIES; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; INFECTION; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASMS; PERITONEAL DIALYSIS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SPAIN; TREATMENT OUTCOME;

EID: 79954512511     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: 10.3265/Nefrologia.pre2011.Jan.10743     Document Type: Article

References (54)

1. Remón Rodríguez C, Quirós Ganga PL, Portolés J, Marrón B. Análisis crítico de los estudios de supervivencia en diálisis. Nefrologia 2010;1(Supl Ext 1):8-14.
2. McDonald SP, Marshall MR, Johnson DW, et al. Relationship between dialysis modality and mortality. J Am Soc Nephro 2009;20:155-63.
3. Vonesh EF, Snyder JJ, Foley RN, Collins AJ. Mortality studies comparing peritoneal dialysis and hemodialysis: What do they tell us? Kidney Int 2006;70:S3-S11.
4. Bloembergen WE, Port FK, Mauger EA, Wolfe RA. A comparison of mortality between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 1995;6(2):177-83.
5. Mehrotra R, Chiu YW, Kalantar-Zadeh K, Bargman J. Similar Outcomes With Hemodialysis and Peritoneal Dialysis in Patients With End-Stage Renal Disease. Arch Intern Med 2010;Sep 27.
6. Vonesh EF, Moran J. Mortality in end-stage renal disease: A reassessment of differences between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 1999;10:354-65.
7. Korevaar RT, Feith GW. Dekker FW, et al. Effect of starting with hemodialysis compared with peritoneal dialysis in patients new on dialysis treatment: A randomized controlled trial. Kidney Int 2003;64:2222-8.
8. Weinhandl ED, Foley RN, Gilbertson DT, Arneson TJ, Snyder JJ, Collins AJ. Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patients. J Am Soc Nephrol 2010;21:499-506.
9. Van Manen JF, Van Dijk PC, Stel V, et al. Confoundign effect of comorbidity in survival studies in patients on renal replacement therapy. Nephrol Dial Transplant 2007;22:187-95.
10. Winkelmayer WC, Glynn RJ, Mittleman MA, Levin R, Pliskin JS, Avorn J. Comparing mortality of elderly patients on hemodialysis versus peritoneal dialysis: a propensity score approach. J Am Soc Nephrol 2002;13:2353-62.
11. Liem YS, Wong JB, Hunink MGM, et al. Comparison of hemodialysis and peritoneal dialysis survival in The Netherlands. Kidney Int 2007;71:153-8.
12. Miskulin DC, Meyer KB, Athienites NV, et al. Comorbidity and other factors associated with modality selection in incident dialysis patients: The CHOICE study. Am J Kidney Dis 2002;39:324-36.
13. Huisman RM, Martin GM, et al. Patients-related and centre-related factors influencing technique survival of peritoneal dialysis in The Netherlands. Nephrol Dial Transplant 2002;17:1655-60.
14. Keshaviah P, Collins AJ, Ma JZ, et al. Survival comparison between hemodialysis and peritoneal dialysis based on matched doses of de-ivered therapy. J Am Soc Nephrol 2002;13:S48-S52.
15. Korevaar RT, Feith GW, Dekker FW, et al. Effect of starting with hemodialysis compared with peritoneal dialysis in patients new on dialysis treatment: A randomized controlled trial. Kidney Int 2003;64:2222-8.
16. Termorshuizen F, Korevaar JC, Dekker FW, Van Manen JG, Boescho-ten EW, Krediet RT. Hemodialysis and peritoneal dialysis: comparison of adjusted mortality rates according to the duration of dialysis analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis 2. J Am Soc Nephrol 2003;14:2851-60.
17. Van Biesen W, Vanholder R, Debacquer D, et al. Comparison of survival on CAPD and haemodialysis: statistical pitfalls. Nephrol Dia Transplant 2000;15:307-11.
18. Dekker FW, De Mutsert R, Van Dijk PC, Zoccali C, Jager KJ. Surviva analysis: time-dependent effects and time-varying risk factors. Kidney Int 2008;74:994-7.
19. Murphy SW, Foley RN, Barrett BJ, et al. Comparative mortality of hemodialysis and peritoneal dialysis in Canada. Kidney Int 2000;57:1720-6.
20. Ross S, Dong E, Gordon M, Connelly J et al. Meta-analysis of outcome studies in edn-stage renal disease. Kidney Int 2000;57(Supp 74):S28-38.
21. Jaar BG, Coresh J, Plantinga LC, Fink NE, Klag MJ, Levey AS, et al Comparing the risk for death with peritoneal dialysis and hemodialysis in a national cohort of patients with chronic kidney disease. Ann Intern Med 2005;143(3):174-83.
22. Mendelssohn DC, Mujais SK, Soroka SD, Brouillette J, Takano T, Barre PE, et al. A prospective evaluation of renal replacement therapy modality eligibility. Nephrol Dial Transplant 2009;24(2):555-61.
23. Han SH, Ahn SV, Yun JY, Tranaeus A, Han DS. Mortality and technique failure in peritoneal dialysis patients using advanced peritonea dialysis solutions. Am J Kidney Dis 2009;54(4):711-20.
24. Feriani M, Kirchgessner J, La Greca G, Passlick-Deetjen J. Randomized long-term evaluation of bicarbonate-buffered CAPD solution. Kidney Int 1998;54(5):1731-8.
25. Montenegro J, Saracho R, Gallardo I, Martínez I, Muñoz R, Quinta-nilla N. Use of pure bicarbonate-buffered peritoneal dialysis fluid reduces the incidence of CAPD peritonitis. Nephrol Dial Transplant 2007;22(6):1703-8.
26. Ahmad S, Sehmi JS, Ahmad-Zakhi KH, Clemenger M, Levy JB, Brown EA. Impact of new dialysis solutions on peritonitis rates. Kidney Int Suppl 2006; 103:S63-6.
27. Mortier S, Faict D, Lameire NH, De Vriese AS. Benefits of switching from a conventional to a low-GDP bicarbonate/lactate-buffered dialysis solution in a rat model. Kidney Int 2005;67(4):1559-65.
28. Williams JD, Topley N, Craig KJ, Mackenzie RK, Pischetsrieder M, Lage C, et al., Euro Balance Trial Group. The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane. Kidney Int 2004;66(1):408-18.
29. Bajo MA, Del Peso G, Sánchez-Villanueva R, Castro MJ, Aroeira L, Selgas R. New peritoneal dialysis solutions and their combinations. Nefrologia 2008;28 (Suppl 6):59-66.
30. Witowski J, Korybalska K, Ksiazek K, Wisniewska-Elnur J, Jörres A, Lage C, et al. Peritoneal dialysis with solutions low in glucose degradation products is associated with improved biocompatibility profile towards peritoneal mesothelial cells. Nephrol Dial Transplant 2004;19(4):917-24.
31. Yáñez-Mó M, Lara-Pezzi E, Selgas R, Ramírez-Huesca M, Domínguez-Jiménez C, Jiménez-Heffernan JA, et al. Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med 2003;348(5):403-13.
32. Bajo MA, Pérez-Lozano ML, Albar-Vizcaíno P, Del Peso G, Castro MJ, González-Mateo G, et al. Low-GDP peritoneal dialysis fluid («balance») has less impact in vitro and ex vivo on epithelial-to-mesenchymal transition (EMT) of mesothelial cells than a standard fluid. Nephrol Dial Transplant 2010. Jun 22, [Epub ahead of print].
33. Locatelli F, Marcelli D, Conte F, D'Amico M, Del Vecchio L, Limido A, et al. Survival and development of cardiovascular disease by modality of treatment in patients with end-stage renal disease. J Am Soc Nephrol 2001;12:2411-7.
34. Canada-USA (CANUSA) Peritoneal dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. J Am Soc Nephrol 1996;7:198-207.
35. Yeates KE, Zhu N, Vonesh E, et al. Survival of patients receiving hemodialysis versis peritoneal dialysis in Canada: 1991-2000 with follov-up to 2005. J Am Soc Nephrol 2008;19:abstract 279A.
36. Locatelli F, Marcelli D, Conte F. Dialysis patient outcomes in Europe vs the USA. Nephrol Dial Transplant 1997;12:1816-9.
37. Foley RN, Parfrey PS, Harnett JD, et al. Mode of dialysis therapy and mortality in end-stage renal disease. J Am Soc Nephrol 1998;9:267-76.
38. Kramer A, Stel V Zoccali C, Heaf J, Ansell D, Grönhagen-Riska C, et al., ERA-EDTA Registry. An update on renal replacement therapy in Europe: ERA-EDTA Registry data from 1997 to 2006. Nephrol Dia Transplant 2009;24(12):3557-66.
39. Mehrotra R, Chiu YW, Kalantar-Zadeh K, Vonesh E. The outcomes of continuous ambulatory and automated peritoneal dialysis are similar. Kidney Int 2009;76(1):97-107.
40. Ganesh SK, Hulbert-Shearon T, Port FK, Eagle K, Stack AG. Mortality differences by dialysis modality among incident ESRD patients with and without coronary artery disease. J Am Soc Nephro 2003;14(2):415-24.
41. De Jonge H, Bammens B, Lemahieu W, Maes BD, Vanrenterghem Y Comparison of peritoneal dialysis and haemodialysis after rena transplant failure. Nephrol Dial Transplant 2006;21(6):1669-74.
42. Vonesh EF, Snyder JJ, Foley RN, Collins AJ. The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis. Kidney Int 2004;66(6):2389-401.
43. Lee HY, Park HC, Seo BJ, Do JY, Yun SR, Song HY, et al. Superior patient survival for continuous ambulatory peritoneal dialysis patients treated with a peritoneal dialysis fluid with neutral pH and low glucose degradation product concentration (Balance). Perit Dial Int 2005;25(3):248-55.
44. McIntyre CW. Update on peritoneal dialysis solutions. Kidney Int 2007;71(6):486-90.
45. Fan SL, Pile T, Punzalan S, Raftery MJ, Yaqoob MM. Randomized controlled study of biocompatible peritoneal dialysis solutions: effect on residual renal function. Kidney Int 2008;73(2):200-6.
46. Choi HY, Kim DK, Lee TH, Moon SJ, Han SH, Lee JE, et al. The clinical usefulness of peritoneal dialysis fluids with neutral pH and low glucose degradation product concentration: an open randomized prospective trial. Perit Dial Int 2008;28(2):174-82.
47. Grzegorzewska AE. Biocompatible peritoneal dialysis solutions: do they indeed affect the outcome? Pol Arch Med Wewn 2009;119(4):242-7.
48. Lorenzo V, Martín M, Rufino M, Hernández D, Torres A, Ayus JC. Predialysis nephrologic care and a functioning arteriovenous fistula at entry are associated with better survival in incident hemodialysis patients: an observational cohort study. Am J Kidney Dis 2004;43(6):999-1007.
49. Marrón B, Ortiz A, De Sequera P, Martín-Reyes G, De Arriba G, Lamas JM, et al., Spanish Group for CKD. Impact of end-stage rena disease care in planned dialysis start and type of renal replacement therapy-a Spanish multicentre experience. Nephrol Dial Transplant 2006;21(Suppl 2):ii51-5.
50. Arrieta J. Evaluación económica del tratamiento sustitutivo renal (he-modiálisis, diálisis peritoneal y trasplante) en España. Nefrologia 2010;1(Supl. Ext.):37-47.
51. Selgas R. Calidad y sostenibilidad del tratamiento sustitutivo renal Editor especial. Nefrología 2010;1(Supl. Ext.):1.
52. Portolés J, Remón C. En busca de la eficiencia y la sostenibilidad del tratamiento renal sustitutivo integrado. Nefrologia 2010;1(Supl. Ext.):2-7.
53. Berger A, Edelsberg J, Inglese GW, Bhattacharyya SK, Oster G. Cost comparison of peritoneal dialysis versus hemodialysis in end-stage renal disease. Am J Manag Care 2009;15(8):509-18.
54. Coronel F, Cigarrán S, Herrero JA. Morbimortalidad en pacientes diabéticos en diálisis peritoneal. Experiencia de 25 años en un solo centro. Nefrologia 2010. En prensa.